CelAgace™ OraRinse (CAOR) Pilot Clinical Study for Management of Candidiasis Associated With Grade 0-II Mucositis
CelAgace™ OraRinse (silver citrate complex and acemannan) Solution is planned to be evaluated for safety and effectiveness as a potential treatment for candidiasis, a yeast infection, commonly known as thrush, which is associated with mouth sores.
100 Clinical Results associated with CelaCare Technologies
0 Patents (Medical) associated with CelaCare Technologies
100 Deals associated with CelaCare Technologies
100 Translational Medicine associated with CelaCare Technologies